Deep Medicine Acquisition (Deep Medicine Acquisition) Equity-to-Asset : -0.13 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Deep Medicine Acquisition's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-0.89 Mil. Deep Medicine Acquisition's Total Assets for the quarter that ended in Sep. 2023 was $7.01 Mil.

The historical rank and industry rank for Deep Medicine Acquisition's Equity-to-Asset or its related term are showing as below:

DMAQ' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.26 Med: 0.26 Max: 0.96
Current: -0.13

During the past 3 years, the highest Equity to Asset Ratio of Deep Medicine Acquisition was 0.96. The lowest was -0.26. And the median was 0.26.

DMAQ's Equity-to-Asset is not ranked
in the Diversified Financial Services industry.
Industry Median: 0.81 vs DMAQ: -0.13

Deep Medicine Acquisition Equity-to-Asset Historical Data

The historical data trend for Deep Medicine Acquisition's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deep Medicine Acquisition Equity-to-Asset Chart

Deep Medicine Acquisition Annual Data

Trend

Mar21

Mar22

Mar23

Equity-to-Asset

-0.02

0.96

0.26

Deep Medicine Acquisition Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Equity-to-Asset	Get a 7-Day Free Trial							0.96	0.32	0.26	0.23	-0.13

Competitive Comparison of Deep Medicine Acquisition's Equity-to-Asset

For the Shell Companies subindustry, Deep Medicine Acquisition's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deep Medicine Acquisition's Equity-to-Asset Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Deep Medicine Acquisition's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Deep Medicine Acquisition's Equity-to-Asset falls into.

Deep Medicine Acquisition Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Deep Medicine Acquisition's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2.554	/	9.777
	=

Deep Medicine Acquisition's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-0.892	/	7.005
	=

Deep Medicine Acquisition (NAS:DMAQ) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Deep Medicine Acquisition Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

Deep Medicine Acquisition Corp is a blank check company.

Executives

John Chiang	director	3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong	director	2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen	director, officer: Chief Executive Officer	C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo	officer: Chief Financial Officer	40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc	10 percent owner	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017